<DOC>
	<DOCNO>NCT01303562</DOCNO>
	<brief_summary>The goal placebo-controlled , 3-way crossover study determine acute ( 24-h ) bioavailability pharmacokinetics major phytochemical find whole barley oat , well effect select measure antioxidation , inflammation , insulin sensitivity/glucose regulation , vascular remodel follow challenge oral glucose tolerance test ( OGTT ) .</brief_summary>
	<brief_title>Clinical Assessment Barley Oat Phytochemicals</brief_title>
	<detailed_description />
	<criteria>Men postmenopausal woman BMI 2735.9 kg/m2 Cigarette smoking and/or nicotine replacement use Individuals take estrogen Use cholesterollowering medication Use blood pressurelowering medication Regular use stomach acidlowering medication laxative ( include fiber supplement ) Cardiovascular ( heart ) disease Gastrointestinal disease Kidney disease Endocrine disease : include diabetes , untreated thyroid disease Rheumatoid arthritis Active treatment type cancer , except basal cell carcinoma , within 1 year prior study admission Systolic blood pressure &gt; 150 mmHg and/or diastolic blood pressure &gt; 95 mmHg Regular use oral steroid Regular daily intake â‰¥ 2 alcoholic drink Infrequent excessive number regular bowel movement Illicit drug use Vegetarians No fish oil supplement ( include cod liver oil ) one month prior study admission No dietary supplement , include contain vitamin , mineral , herb , plant concentrate ( include garlic , gingko , St. John 's wort ) homeopathic remedy , one month prior study admission</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>oat</keyword>
	<keyword>barley</keyword>
	<keyword>whole grain</keyword>
	<keyword>bioavailability</keyword>
	<keyword>phytochemical</keyword>
</DOC>